Clinical trial
Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma
NCT00149565 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00149565 |
|---|---|
| Title | Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma |
| Official title | Hepatocellular Carcinoma Postoperative Adjuvant Therapy Disease Committee of Taiwan Cooperative Oncology Group |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | Chang Gung Memorial Hospital Tri-Service General Hospital National Taiwan University Hospital Taipei Veterans General Hospital, Taiwan Mackay Memorial Hospital China Medical University Hospital |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Drug |
| Interventions | IFN-α2b |
| Enrollment | 268 |
| Start date | Oct 1, 1997 |
| Completion | Jul 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | Dec 16, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: